Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Alexandra A. Mourad-Zeidan"'
Publikováno v:
The American Journal of Pathology. 173:1839-1852
Galectin-3 (Gal-3) is a beta-galactoside-binding protein that is involved in cancer progression and metastasis. Using a progressive human melanoma tissue microarray, we previously demonstrated that melanocytes accumulate Gal-3 during the progression
Publikováno v:
Journal of Biological Chemistry. 281:2911-2922
Overexpression of cAMP-response element (CRE)-binding protein (CREB) and activating transcription factor (ATF) 1 contributes to melanoma progression and metastasis at least in part by promoting tumor cell survival and stimulating matrix metalloprotei
Autor:
Whitney A. Spannuth, Menashe Bar-Eli, William M. Merritt, Alpa M. Nick, Anil K. Sood, Marc E. Lenburg, Hua Wang, Samuel C. Mok, Michael T. Deavers, Gabriel Lopez-Berestein, Liz Y. Han, Alexandra A. Mourad-Zeidan, Len A. Pennacchio, Joe W. Gray, Peter R. Mueller, Michael J. Birrer, Rosemarie Schmandt, Yvonne G. Lin, Diana L. Urbauer, Robert L. Coleman, Aparna A. Kamat, Jan Fang Cheng
Publikováno v:
Merritt, W.M.; Lin, Y.G.; Han, L.Y.; Karnat, Aa.; Spannuth, W.A.; Schmandt, R.; et al.(2008). Dicer, Drosha, and outcomes in patients with ovarian cancer. New England Journal of Medicine, 359. Lawrence Berkeley National Laboratory: Lawrence Berkeley National Laboratory. Retrieved from: http://www.escholarship.org/uc/item/2t74z8db
BACKGROUND: We studied Dicer and Drosha, components of the RNA-interference machinery, in ovarian cancer. METHODS: We measured messenger RNA (mRNA) levels of Dicer and Drosha in specimens of invasive epithelial ovarian cancer from 111 patients, using
Autor:
Yang Zhao, Liana Adam, Alexandra A. Mourad-Zeidan, B. Schwartz, Vladislava O. Melnikova, Marya F. McCarty, Carmen Tellez, Menashe Bar-Eli, K. Blehm
Publikováno v:
Oncogene. 26(28)
Activator protein-2 (AP-2) is a transcription factor that regulates proliferation and differentiation in mammalian cells and has been implicated in the acquisition of the metastatic phenotype in several types of cancer. Herein, we examine the role of
Autor:
Marcella M. Johnson, Alexandra A. Mourad-Zeidan, Jeffrey E. Gershenwald, Menashe Bar-Eli, Alexander J. Lazar, Jon A. Reed, Avraham Raz, Peter Zhang, A. Hafeez Diwan, Victor G. Prieto, Vladislava O. Melnikova, Steven S. Shen, Adriana Lopez
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research. 12(22)
Purpose: Most studies accept a multistep pathogenic process in melanoma that may include the phases of benign nevi and dysplastic nevi, melanoma, and metastatic melanoma. Dysregulation of cellular proliferation and apoptosis is probably involved in m
Autor:
Merritt WM; University of Texas M.D. Anderson Cancer Center, Houston, TX 77230, USA., Lin YG, Han LY, Kamat AA, Spannuth WA, Schmandt R, Urbauer D, Pennacchio LA, Cheng JF, Nick AM, Deavers MT, Mourad-Zeidan A, Wang H, Mueller P, Lenburg ME, Gray JW, Mok S, Birrer MJ, Lopez-Berestein G, Coleman RL, Bar-Eli M, Sood AK
Publikováno v:
The New England journal of medicine [N Engl J Med] 2008 Dec 18; Vol. 359 (25), pp. 2641-50.